- $4.05bn
- $4.05bn
- $2.47bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.18 | ||
| Price to Tang. Book | 1.18 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.64 | ||
| EV to EBITDA | 67.58 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.93% | ||
| Return on Equity | -3.25% | ||
| Operating Margin | -2.79% | ||
Financial Summary
| Year End 26th Apr | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 2,245 | 2,469 | n/a | n/a | 9.98% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Directors
- Last Annual
- April 26th, 2024
- Last Interim
- January 1st, 1970
- Incorporated
- February 27th, 2025
- Public Since
- March 6th, 2026
- No. of Employees
- 8,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 280,813,348
- Address
- 18000 Devonshire St., NORTHRIDGE, 91325
- Web
- Phone
- +1 3026365401
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for MMED
Q4 2025 MiniMed Group Inc Earnings Call
Similar to MMED
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Alamar Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Minimed share price?
As of Today at 22:05 UTC, shares in Minimed are trading at $14.44. This share price information is delayed by 15 minutes.
How has the Minimed share price performed this year?
Shares in Minimed last closed at $14.44 and the price had moved by over the past 365 days. In terms of relative price strength the Minimed share price has matched the S&P500 Index by over the past year.
What are the analyst and broker recommendations for Minimed?
There is no consensus recommendation for this security.
Find out moreWhat is the Minimed dividend yield?
Minimed does not currently pay a dividend.
Does Minimed pay a dividend?
Minimed does not currently pay a dividend.
When does Minimed next pay dividends?
Minimed does not currently pay a dividend.
How do I buy Minimed shares?
To buy shares in Minimed you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Minimed?
As of the previous close price of $14.44, shares in Minimed had a market capitalisation of $4.05bn.
Where are Minimed shares listed?
Here are the trading details for Minimed:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: MMED
What kind of share is Minimed?
Based on an overall assessment of its quality, value and momentum Minimed is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Minimed share price forecast for 2026?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Minimed share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Minimed. Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $14.44, shares in Minimed were trading -7.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Minimed PE Ratio?
The Minimed PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $14.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Minimed?
We do not have data on Minimed's directors